MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0020827
Sambi Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹10.55 Cr
Latest filing
Net profit · FY 2023
₹12.81 Lakh
Net margin 1.2%
EBITDA · FY 2023
-₹19.14 Lakh
EBITDA margin -1.8%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹60 Lakh
Issued & subscribed
Open charges
₹8.08 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
45
Provident fund records
About Sambi Pharma Private Limited
Data last updated:
Sambi Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2019PTC132115. Its GSTIN is 36ABBCS9266R1ZD (Telangana).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹60 Lakh. It is led by directors including Krishnareddy Sambireddy and Sandesh Reddy Korandla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 100 Raidurga Gachibowli, Hyderabad, Telangana, India – 500060.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.55 Cr. For the same year it recorded a net profit of ₹12.81 Lakh (net margin 1.2%) and EBITDA of -₹19.14 Lakh (EBITDA margin -1.8%). Revenue has grown at a compounded annual rate (CAGR) of 128% over three years.
The company has about 45 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sambi Pharma. As per MCA filings, the company has open charges of ₹8.08 Cr on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹50 Lakh; the latest was in February 2021.
Sambi Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0020827). For more details, the company can be reached via its website sambipharma.com.
Company details
CIN U74999TG2019PTC132115
Registration Number 132115
Incorporation Date 18 April 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-TS-02-0020827
Key People
Krishnareddy Sambireddy Director Sandesh Reddy Korandla Director Venkat Narsimhareddy Sambi Director Recognitions & Rankings of Sambi Pharma
Contact details
Sambi Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is sambipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address100 Raidurga Gachibowli, Hyderabad, Telangana, India – 500060
- IndustryPharma, Pharmaceutical Retailers & Distributors, Pharma Contract R&D
To see the full contact details of Sambi Pharma Private Limited, buy the company report.
Comprehensive company report
Sambi Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sambi Pharma operates one associated brand: Sambi Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers chemistry services for drug discovery, R&D, and manufacturing in pharmaceuticals. | sambipharma.com |
Financials of Sambi Pharma Private Limited
FY 2024 filings availableSambi Pharma Private Limited reported revenue of ₹10.55 Cr for FY 2023.
Revenue · FY 2023
₹10.55 Cr
Net profit · FY 2023
₹12.81 Lakh margin 1.2%
EBITDA · FY 2023
-₹19.14 Lakh margin -1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 128%
Revenue has grown at a compounded annual rate (CAGR) of 128% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹10.55 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹19.14 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹12.81 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.8% | |||
| Net Profit Margin | 1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sambi Pharma Private Limited, buy the company report.
Board of directors of Sambi Pharma Private Limited
Sambi Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnareddy Sambireddy Also directs: Sambi Life Sciences Private Limited, Sambtek Forex Limited | Director | 18 Apr 2019 | 7 Years 6 Months | Current |
| Sandesh Reddy Korandla | Director | 18 Apr 2019 | 7 Years 6 Months | Current |
| Venkat Narsimhareddy Sambi Also directs: Devas Developers LLP, Sambi Life Sciences Private Limited, Sambi Sciences Private Limited and 5 more | Director | 18 Apr 2019 | 7 Years 6 Months | Current |
Auditor
Sambi Pharma Private Limited is audited by RAJESHAM BANDARI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESHAM BANDARI | FY 2023 | 233004 |
Shareholding
The shareholding of Sambi Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sambi Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.08 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2024 | 101071924 | Canara Bank | ₹24.76 Lakh | Open | |
| 04 May 2024 | 100920487 | Axis Bank Limited | ₹2.5 Cr | Open | |
| 08 Dec 2023 | 100829580 | Canara Bank | ₹80 Lakh | Open | |
| 28 Jul 2022 | 100625156 | Hdfc Bank Limited | ₹11.55 Lakh | Open | |
| 26 Mar 2021 | 100441181 | Canara Bank | ₹4.42 Cr | Open |
To see the full charge records of Sambi Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Sambi Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹50 Lakh; the latest was in February 2021.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹50 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Funding round | ₹50 Lakh | Investors: 3 individuals |
| Apr 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Sambi Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sambi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sambi Pharma Private Limited has a workforce of 45 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
45
Active EPFO establishments
1
Employee growth
-30.77%
GST
Sambi Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABBCS9266R1ZD | Telangana | Active | 17 May 2019 |
To see the full GST registrations and return filing status of Sambi Pharma Private Limited, buy the company report.
Recent activity
Sambi Pharma Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Hanmanth Pradeep Reddy ceased to be Director on 30 Jun 2025.
Ceased
Hanmanth Pradeep Reddy ceased to be Director.
Ceased
Madhavi Reddy Sambireddy ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 24.76 Lakh with Charge ID 101071924 was registered on 27 Dec 2024.
AGM
Sambi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 249.95 Lakh with Charge ID 100920487 was registered on 04 May 2024.
Filing
Sambi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Canara Bank amounted to Rs. 80.00 Lakh with Charge ID 100829580 was registered on 08 Dec 2023.
Charges
A charge with Canara Bank of Rs. 442.00 Lakh registered on 26 Mar 2021 with Charge ID 100441181 was modified on 01 Oct 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 11.55 Lakh with Charge ID 100625156 was registered on 28 Jul 2022.
Charges
A charge with Canara Bank amounted to Rs. 442.00 Lakh with Charge ID 100441181 was registered on 26 Mar 2021.
Ceased
Leleti Mamatha ceased to be Additional Director.
Ceased
Leleti Reddy Rajender ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Sambi Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2019 (7+ years old) and is registered under CIN U74999TG2019PTC132115.
Sambi Pharma has 3 current directors:
- Krishnareddy Sambireddy - Director
- Sandesh Reddy Korandla - Director
- Venkat Narsimhareddy Sambi - Director
The latest financial statements of Sambi Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sambi Pharma is 36ABBCS9266R1ZD, registered in Telangana.
The CIN (Corporate Identification Number) of Sambi Pharma is U74999TG2019PTC132115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sambi Pharma was incorporated on 18 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sambi Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹50 Lakh; the latest was in February 2021.
Hanmanth Pradeep Reddy ceased to be Director on 30 Jun 2025. Madhavi Reddy Sambireddy ceased to be Director on 30 Jun 2025. Leleti Mamatha ceased to be Additional Director on 12 Jun 2020. Sambi Pharma has 7 board changes on record in total.
Yes, Sambi Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0020827).
Sambi Pharma can be reached through the website sambipharma.com. Its registered office is in Hyderabad, Telangana, India.